Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1+ CD8+ T cells in HCC via blocking VEGFR2.
- Resource Type
- Article
- Source
- Cancer Science; Apr2023, Vol. 114 Issue 4, p1284-1296, 13p
- Subject
- Language
- ISSN
- 13479032